Visualizing CTL activity for different CD8+ effector T cells supports the idea that lower TCR/epitope avidity may be advantageous for target cell killing

Cell Death and Differentiation

Volumn 16, Issue 4, 2009, Pages 537-542

  Jenkins, M R ^a   La Gruta, N L ^a   Doherty, P C ^a,b   Trapani, J A ^c   Turner, S J ^a   Waterhouse, N J ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL MEMBRANE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; INFLUENZA; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL DESTRUCTION; VIRUS PNEUMONIA;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPITOPES; INFLUENZA A VIRUS; MICE; MICROSCOPY, VIDEO; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

INFLUENZA A VIRUS; MUS;

EID: 62849092944     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.176     Document Type: Article

References (20)

1. Topham DJ, Tripp RA, Doherty PC. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997; 159: 5197-5200.
2. Lowin B, Peitsch MC, Tschopp J. Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol 1995; 198: 1-24.
3. Smyth MJ, Street SE, Trapani JA. Cutting edge: Granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 2003; 171: 515-518.
4. Waterhouse NJ, Sutton VR, Sedelies KA, Ciccone A, Jenkins M, Turner SJ et al. Cytotoxic T lymphocyte-induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis. J Cell Biol 2006; 173: 133-144.
5. Jenkins MR, Kedzierska K, Doherty PC, Turner SJ. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol 2007; 179: 64-70.
6. Jenkins MR, Trapani JA, Doherty PC, Turner SJ. Granzyme K expressing CTL protect against influenza virus in granzyme AB-/- mice. Viral Immunol 2008; 21: 341-346.
7. Stambas J, Doherty PC, Turner SJ. An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8(+) T cells. J Immunol 2007; 178: 1285-1292.
8. Turner SJ, Diaz G, Cross R, Doherty PC. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity 2003; 18: 549-559.
9. Kedzierska K, Turner SJ, Doherty PC. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Natl Acad Sci USA 2004; 101: 4942-4947.
10. La Gruta NL, Doherty PC, Turner SJ. A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8(+) T cell responses. Eur J Immunol 2006; 36: 2951-2959.
11. La Gruta NL, Turner SJ, Doherty PC. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: Correlation of cytokine profile and TCR avidity. J Immunol 2004; 172: 5553-5560.
12. Belz GT, Xie W, Altman JD, Doherty PC. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol 2000; 74: 3486-3493.
13. Kedzierska K, La Gruta NL, Davenport MP, Turner SJ, Doherty PC. Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses. Proc Natl Acad Sci USA 2005; 102: 11432-11437.
14. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12 48-54.
15. Belz GT, Stevenson PG, Doherty PC. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 2000; 165: 2404-2409.
16. Turner SJ, La Gruta NL, Stambas J, Diaz G, Doherty PC. Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells. Proc Natl Acad Sci USA 2004; 101: 3545-3550.
17. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, Webb AI et al. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol 2005; 6: 382-389.
18. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004; 5: 524-530.
19. Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med 1995; 181: 577-584.
20. Crowe SR, Turner SJ, Miller SC, Roberts AD, Rappolo RA, Doherty PC et al. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 2003; 198: 399-410.